Hims & Hers CLO sells 6,236 shares at $27.86

Hims & Hers Health’s Chief Legal Officer reported a Rule 10b5-1–planned sale of 6,236 Class A shares, leaving 304,270 shares held directly.

Available on EDGAR 09/17/2026 - 04:17 PM EDT Accepted by SEC EDGAR 09/17/2026 - 04:17 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Hims & Hers Health, Inc. (HIMS) reported that its Chief Legal Officer, Soleil Boughton, sold 6,236 shares of Class A Common Stock on September 16, 2026 at $27.86 per share in an open market or private transaction. After this sale, the officer directly holds 304,270 shares. The sale was effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2026.

Insider Trade Summary 10b5-1

Net Seller: 6,236 shares

Net Sell 1 txn

Insider Boughton Soleil

Role Chief Legal Officer

Sold 6,236 shs ($174K)

Share of Position Sold 2.0%

Type	Security	Shares	Price	Value
Sale	Class A Common Stock F1	6,236	$27.86	$174K

Holdings After Transaction: Class A Common Stock — 304,270 shares (Direct)

Holdings Before and After: Class A Common Stock, 310,506 to 304,270 shares (Direct)

Other Insiders: 4 other insiders reported open-market sales of this stock in the 30 days up to this filing.

Footnotes (1)

1. F1. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2026 by the Reporting Person.

Key Figures

Shares sold: 6,236 shares Sale price per share: $27.86 per share Shares held after transaction: 304,270 shares +2 more

5 metrics

Shares sold 6,236 shares Class A Common Stock sale on September 16, 2026

Sale price per share $27.86 per share Price for the 6,236 Class A shares sold on September 16, 2026

Shares held after transaction 304,270 shares Direct holdings of the Chief Legal Officer after the reported sale

Net shares sold 6,236 shares Net-sell direction across all transactions reported in this Form 4

Rule 10b5-1 plan adoption date May 21, 2026 Date the trading plan governing the reported sale was adopted

Key Terms

Rule 10b5-1 trading plan, Class A Common Stock, open market or private transaction

3 terms

Rule 10b5-1 trading plan regulatory

"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

Class A Common Stock financial

"security title is listed as Class A Common Stock for the transaction"

Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.

open market or private transaction financial

"transaction code description notes a Sale in open market or private transaction"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did HIMS disclose for Soleil Boughton?

Hims & Hers Health disclosed that Chief Legal Officer Soleil Boughton sold 6,236 shares of Class A Common Stock on September 16, 2026 at $27.86 per share, leaving 304,270 shares held directly after the transaction.

Was the recent HIMS insider sale made under a Rule 10b5-1 plan?

Yes. The filing states the sales were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2026 by the reporting person, and the plan-status checkbox on the form is also affirmed.

How many HIMS shares did the Chief Legal Officer sell and at what price?

The Chief Legal Officer sold 6,236 shares of Hims & Hers Health Class A Common Stock at a price of $27.86 per share in a sale described as an open market or private transaction.

How many HIMS shares does the Chief Legal Officer hold after the reported sale?

Following the reported transaction, the Chief Legal Officer directly holds 304,270 shares of Hims & Hers Health Class A Common Stock, as disclosed in the Form 4’s post-transaction holdings field.

What role does Soleil Boughton hold at Hims & Hers Health (HIMS)?

Soleil Boughton is identified in the filing as the company’s Chief Legal Officer, and is the reporting person for the disclosed sale of Class A Common Stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Boughton Soleil

(Last) (First) (Middle)

2269 CHESTNUT STREET, #523

(Street)

SAN FRANCISCO CALIFORNIA 94123

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Hims & Hers Health, Inc. [ HIMS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Legal Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/16/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	09/16/2026		S(1)		6,236	D	$27.86	304,270	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2026 by the Reporting Person.

Remarks:

	/s/ Kimberly Mather, Attorney-in-Fact for Soleil Boughton	09/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)